Screener
Prime Medicine PRME Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | (3,622) | (1,690) |
| Deferred revenue — related party | (1,984) | (2,433) |
| Lease liabilities | (3,949) | (2,053) |
| Net cash used in operating activities | (83,756) | (90,269) |
| Cash flows provided by (used in) investing activities: | ||
| Maturities of investments | 93,953 | 14,250 |
| Purchases of investments | (26,272) | (55,227) |
| Purchases of property and equipment | (260) | (3,994) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's operating cash flow?
- Prime Medicine (PRME) reported operating cash flow of -$41.05M in Q2 2026.
- How has Prime Medicine's operating cash flow changed year-over-year?
- Prime Medicine's operating cash flow increased by 0.9% year-over-year, from -$41.41M to -$41.05M.
- What is the long-term trend for Prime Medicine's operating cash flow?
- Over 2 years (2022 to 2025), Prime Medicine's operating cash flow has grown at a 11.0% compound annual growth rate (CAGR), from -$131.83M to -$162.56M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Prime Medicine's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude